'Living drug' CAR T therapy shows promise for stiff person syndrome, an autoimmune disease
An experimental CAR T cell therapy may become the first approved treatment for stiff person syndrome. In a clinical trial, one patient regained mobility, but researchers caution it's too early to declare a cure.
Read the story